Clinical Trial Update: Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating interferon-γ-primed mesenchymal stromal cells as prophylaxis for acute graft-versus-host disease in patients with acute myeloid leukemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Interferon-γ-primed mesenchymal stromal cells

Snippet

Sponsor: Edwin Horwitz | Conditions: Acute Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: TERMINATED